These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 12578408)
41. [Effect of preoperative administration of Lugol's solution on thyroid blood flow in hyperthyroidism]. Rodier JF; Janser JC; Petit H; Schneegans O; Ott G; Kaissling A; Grob JC; Velten M Ann Chir; 1998; 52(3):229-33. PubMed ID: 9752450 [TBL] [Abstract][Full Text] [Related]
42. The significance of thyroid blood flow at the inferior thyroid artery as a predictor for early Graves' disease relapse. Ueda M; Inaba M; Kumeda Y; Nagasaki T; Hiura Y; Tahara H; Onoda N; Ishikawa T; Nishizawa Y Clin Endocrinol (Oxf); 2005 Dec; 63(6):657-62. PubMed ID: 16343100 [TBL] [Abstract][Full Text] [Related]
43. Mean peak systolic velocity of the superior thyroid artery is correlated with radioactive iodine uptake in untreated thyrotoxicosis. Chen L; Zhao X; Liu H; Wang Y; Li L; Lu B; Li Y; Hu R J Int Med Res; 2012; 40(2):640-7. PubMed ID: 22613425 [TBL] [Abstract][Full Text] [Related]
44. The effect of preoperative Lugol's iodine on thyroid blood flow in patients with Graves' hyperthyroidism. Chang DC; Wheeler MH; Woodcock JP; Curley I; Lazarus JR; Fung H; John R; Hall R; McGregor AM Surgery; 1987 Dec; 102(6):1055-61. PubMed ID: 3317958 [TBL] [Abstract][Full Text] [Related]
45. Significance of thyroid blood flow as a predictor of methimazole sensitivity in untreated hyperthyroid patients with Graves' disease. Nagasaki T; Inaba M; Kumeda Y; Fujiwara-Ueda M; Hiura Y; Nishizawa Y Biomed Pharmacother; 2007 Sep; 61(8):472-6. PubMed ID: 17420111 [TBL] [Abstract][Full Text] [Related]
46. Color flow Doppler sonography rapidly differentiates type I and type II amiodarone-induced thyrotoxicosis. Bogazzi F; Bartalena L; Brogioni S; Mazzeo S; Vitti P; Burelli A; Bartolozzi C; Martino E Thyroid; 1997 Aug; 7(4):541-5. PubMed ID: 9292940 [TBL] [Abstract][Full Text] [Related]
48. Relationship between the sonographic appearance of the thyroid and the clinical course and autoimmune activity of Graves' disease. Baldini M; Orsatti A; Bonfanti MT; Castagnone D; Cantalamessa L J Clin Ultrasound; 2005 Oct; 33(8):381-5. PubMed ID: 16240426 [TBL] [Abstract][Full Text] [Related]
49. Ultrasonographic Demonstration of the Tissue Microvasculature in Children: Microvascular Ultrasonography Versus Conventional Color Doppler Ultrasonography. Yoo J; Je BK; Choo JY Korean J Radiol; 2020 Feb; 21(2):146-158. PubMed ID: 31997590 [TBL] [Abstract][Full Text] [Related]
50. Doppler ultrasonography in predicting relapse of hyperthyroidism in Graves' disease. Varsamidis K; Varsamidou E; Mavropoulos G Acta Radiol; 2000 Jan; 41(1):45-8. PubMed ID: 10665869 [TBL] [Abstract][Full Text] [Related]
51. Hypervascularity of nontoxic goiter as shown by color-coded Doppler sonography. Barreda R; Kaude JV; Fagien M; Drane WE AJR Am J Roentgenol; 1991 Jan; 156(1):199. PubMed ID: 1772472 [No Abstract] [Full Text] [Related]
52. Quantitative measurement of thyroid blood flow for differentiation of painless thyroiditis from Graves' disease. Ota H; Amino N; Morita S; Kobayashi K; Kubota S; Fukata S; Kamiyama N; Miyauchi A Clin Endocrinol (Oxf); 2007 Jul; 67(1):41-5. PubMed ID: 17437515 [TBL] [Abstract][Full Text] [Related]
53. Thyroid bruit and the underlying 'inferno'. Williams E; Chillag S; Rizvi A Am J Med; 2014 Jun; 127(6):489-90. PubMed ID: 24447837 [No Abstract] [Full Text] [Related]
54. Thyroid blood flow as a useful predictor of relapse of Graves' disease after normal delivery in patients with Graves' disease. Nagasaki T; Inaba M; Fujiwara-Ueda M; Nishio J; Kumeda Y; Hiura Y; Tahara H; Ishimura E; Ishiko O; Nishizawa Y Biomed Pharmacother; 2010 Feb; 64(2):113-7. PubMed ID: 20006462 [TBL] [Abstract][Full Text] [Related]
55. Effect of preoperative iodine in patients with Graves' disease controlled with antithyroid drugs and thyroxine. Kaur S; Parr JH; Ramsay ID; Hennebry TM; Jarvis KJ; Lester E Ann R Coll Surg Engl; 1988 May; 70(3):123-7. PubMed ID: 2457351 [TBL] [Abstract][Full Text] [Related]